Charts
On the Frontlines of Non-Small Cell Lung CancerEpisode from the podcastOn the Frontlines of Non-Small Cell Lung Cancer
Next Episode
Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings

Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings

Released Thursday, 2nd January 2025
Good episode? Give it some love!
Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings

Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings

Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings

Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings

Thursday, 2nd January 2025
Good episode? Give it some love!
Rate Episode
List
About
InsightsPodchaser Pro
Reviews
Credits
Lists
Transcript
spinner
Rate
List
Get this podcast via API

From The Podcast

Catch up on the latest updates on non-small cell lung cancer treatment from the 2024 American Society of Clinical Oncology Annual Meeting, the World Conference on Lung Cancer, and the European Society for Medical Oncology Congress in this exclusive conference coverage series.

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more
Do you host or manage this podcast?
Claim and edit this page to your liking.
,
Podchaser Logo

Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More